IRIDEX Corporation
IRIDEX Corporation (IRIX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
irix · pe ratio · data through Jan 3, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for IRIDEX Corporation (IRIX) measures how much investors pay for each dollar of the company's trailing earnings. IRIX's current PE ratio of N/A is calculated by dividing its stock price of $1.12 by its TTM earnings per share of -$0.19.
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-01-03
PE Ratio History
2006 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%12.8x
MedianQ3 · 75%195.2x
Max
At N/A, IRIX's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IRIDEX CorporationYou IRIX | $19M | N/A | — | -$0.19 |
 Adagio Medical Holdings, Inc. ADGM | $11M | N/A | — | -$1.51 |
 Allurion Technologies Inc. ALUR | $6M | N/A | — | -$0.38 |
 Aspire Biopharma Holdings, Inc. ASBP | $1M | N/A | — | -$16.38 |
 Envoy Medical, Inc. COCH | $14M | N/A | — | -$1.21 |
 Hoth Therapeutics, Inc. HOTH | $18M | N/A | — | -$0.90 |
 Inspira Technologies Oxy B.H.N. Ltd. IINN | $45M | N/A | — | -$0.45 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-01-03Latest FY2026 | — | $-0.26 | — | |
2024-12-31 FY2024 | — | $-0.54 | — | |
2023-12-31 FY2023 | — | $-0.59 | — | |
2022-12-31 FY2022 | — | $-0.47 | — | |
2021-12-31 FY2021 | — | $-0.34 | — | |
2020-12-31 FY2020 | — | $-0.46 | — | |
2019-12-31 FY2019 | — | $-0.64 | — | |
2018-12-31 FY2018 | — | $-1.05 | — | |
2017-12-31 FY2017 | — | $-1.11 | — | |
2016-12-31 FY2016 | — | $-1.15 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IRIDEX Corporation (IRIX) measures how much investors pay for each dollar of the company's trailing earnings. IRIX's current PE ratio of N/A is calculated by dividing its stock price of $1.12 by its TTM earnings per share of -$0.19.
Frequently asked questions
IRIX pe ratio · 6 questionsIRIX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.12 and TTM EPS of -$0.19. Data sourced from Financial Modeling Prep via IRIX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IRIDEX Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09